A gene called SDF4 may help brain tumors grow
Original title: Integrative transcriptomic and experimental analyses identifies SDF4 as an astrocyte-expressed regulator of glioma progression through PI3K-AKT signaling.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only lab work on cells and stored tumor data.
The short version
Lab work points to a gene that seems to help glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary tumors grow.
What was studied. Researchers looked at gene activity in glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary tumors using large stored data sets and patient tumor samples. They also grew glioma cells in a dish and shut the SDF4 gene off to see what changed.
What they found. SDF4 was much more active in glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary than it should be. Patients with higher SDF4 levels tended to live shorter lives. When the team shut SDF4 off in cells, the cells grew less and more of them died. The gene showed up mostly in cells called astrocyte: A star-shaped helper cell in the brain and spinal cord. It is one of the glial cells that sit around nerve cells. An astrocytoma starts in these. See the glossary.
What this means, and what it doesn't
What it could mean: SDF4 might one day help doctors judge how serious a glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary is. It may also be a target for drugs that do not exist yet. Nothing here changes treatment today.
What it doesn't mean: This does not mean a new treatment is coming soon. No one was treated in this study. The work was done on cells in a dish and on stored tumor data. It is not a cure, and it is far from everyday care. Much more testing would be needed first.
Source: PubMed, August 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.